Sign up to save your podcasts
Or
Share EGFR Mutant Lung Cancer: Lessons From ASPIRATION and IMPRESS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
EGFR Mutant Lung Cancer: Lessons From ASPIRATION and IMPRESS
Dr Mark Kris discusses the switch from first- to second-line therapy for EGFR mutant lung cancers in light of two studies presented at the most recent ESMO meeting.
View all episodes
By MedscapeDr Mark Kris discusses the switch from first- to second-line therapy for EGFR mutant lung cancers in light of two studies presented at the most recent ESMO meeting.